JSJordan T. Said

Jordan T. Said

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jordan T. Said has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    SJS/TEN following therapy with pembrolizumab and enfortumab vedotin in a patient with urothelial carcinoma

    by Natalie Braun, Vrinda Madan, Sepideh Ashrafzadeh, Jordan Said, Vinod E. Nambudiri


  • Open Access

    Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma

    by Cesar A Virgen, Jeffrey A Sparks, Anju Nohria, Meabh J O’hAre, Amrita Goyal, Jordan T Said, Marianne Tawa, Nicole R LeBoeuf, Thomas S Kupper, David C Fisher, et al.

    Mogamulizumab is being increasingly prescribed for the treatment of T-cell lymphomas (MF/SS/ATLL). We conducted a retrospective cohort study to identify muscular immune-related adverse events (irAEs) associated with mogamulizumab in patients with T-cell lymphoma followed at Dana-Farber Cancer Institute from January 2015 to June 2022. We identified 5 cases of mogamulizumab-associated myositis and/or myocarditis (MAM/Mc), 2 additionally affected by myasthenia gravis, among 42 patients with T-cell lymphoma. Three cases experienced ­mogamulizumab-associated rash (MAR) prior to developing MAM/Mc. The incidence (n = 5/42, 11.9%) of muscular mogamulizumab-associated irAEs may be higher than has been previously reported in clinical trials and may be of late onset (a median of 5 cycles and as late as 100 days from the last infusion). We highlight the utility of IVIG, together with systemic corticosteroids, for the treatment of these potentially fatal side effects associated with mogamulizumab therapy.


  • Pembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report

    by Jordan T Said, Christopher Iriarte, Jordan Talia, Bonnie Leung, Cesar A Virgen, Matthew Robertson, Michael S Rabin, Cecilia Larocca, Nicole R LeBoeuf

    Radiation-induced morphea (RIM) is a rare but distinctive inflammatory complication of therapeutic radiation.1 It most commonly presents as painful sclerosis of the epidermis and dermis limited to the irradiated field. Morphea has also been reported as an immune-related adverse event (irAE) induced by anti-programmed death-1 (PD-1) immune checkpoint inhibitors (ICIs).2,3 We report a patient who first received local radiation therapy to the thorax for lung adenocarcinoma that was complicated by RIM. The patient’s morphea then progressed widely beyond the irradiated field in the setting of pembrolizumab therapy. Histopathology and imaging confirmed morphea extending beyond the irradiated field and with deeper muscular and fascial involvement. Pain and edema progressed through multiple lines of toxicity-directed therapy, but ultimately responded significantly to dupilumab. Response was confirmed clinically and radiographically, and the patient was able to resume ICI therapy. This case report highlights the ability of ICIs to induce progression of pre-existing RIM and supports the consideration of dupilumab in refractory cases.


  • Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review

    by Isabella R. Plumptre, Jordan T. Said, Tiffany Sun, Cecilia Larocca, Cesar A. Virgen, Thomas S. Kupper, David C. Fisher, Philip M. Devlin, Christopher P. Elco, Johanna Sheu Song, et al.

    Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (PCSM-TCLPD) was reclassified in 2016 as a rare benign entity with an excellent prognosis, yet its clinical features and best treatments remain poorly defined. We collected clinical data, treatments, and treatment-responses from our institution's patients with PCSM-TCLPD through September 2018 and an identical PubMed review through June 2021. Among 36 cases (median-age 54 years; 58.3% head/neck), diagnostic biopsy resulted in sustained complete remission (CR) in 13/33 punch/shave biopsies and 3/3 excisional biopsies. The remaining 20 patients further required topical corticosteroids (n = 5); intralesional corticosteroids (n = 1); surgical-excision (n = 5); electron-beam-radiation (n = 6); or brachytherapy (n = 3). All patients ultimately achieved CR, excluding one patient continuing treatment at end-of-study. 57/59 (96.6%) of institutional and literature-reported radiation-treated patients experienced CR. No institutional cases progressed beyond skin; 5/209 (2.4%) literature-reported cases progressed to systemic/extracutaneous involvement, all pre-reclassification. PCSM-TCLPD responds well to local-directed therapy including radiation, and only rarely if ever progresses.


  • Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder in children: A case report and review of the literature

    by Isabella R. Plumptre, Jordan T. Said, Johanna Sheu Song, Kristen Corey, Nicole R. LeBoeuf

    Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder (PCSM‐TCLPD) is a rare benign lymphoproliferative disorder, recently redefined by the 2016 World Health Organization classification of lymphoid neoplasms. In adults, PCSM‐TCLPD responds well to monotherapy with surgical excision or local radiation, with or without topical/injected corticosteroids; in contrast, PCSM‐TCLPD has only rarely been reported in children, in whom treatments favored in adults may be non‐optimal. We present a 14‐year‐old male with PCSM‐TCLPD on the forehead, who achieved complete remission following biopsy, topical corticosteroids, and surgical excision. We also review all literature‐reported cases of pediatric PCSM‐TCLPD, emphasizing the disorder's benign nature and treatment responsiveness in children.


  • Topical tofacitinib for the management of lymphocytic‐variant hypereosinophilic syndrome with cutaneous involvement

    by Jordan T. Said, Scott A. Elman, Marianne Tawa, David C. Fisher, Joseph F. Merola, Thomas S. Kupper


  • Open Access

    3D Printed frames to enable reuse and improve the fit of N95 and KN95 respirators

    by Malia McAvoy, Ai-Tram N. Bui, Christopher Hansen, Deborah Plana, Jordan T. Said, Zizi Yu, Helen Yang, Jacob Freake, Christopher Van, David Krikorian, et al.

    Background: In response to supply shortages caused by the COVID-19 pandemic, N95 filtering facepiece respirators (FFRs or “masks”), which are typically single-use devices in healthcare settings, are routinely being used for prolonged periods and in some cases decontaminated under “reuse” and “extended use” policies. However, the reusability of N95 masks is limited by degradation of fit. Possible substitutes, such as KN95 masks meeting Chinese standards, frequently fail fit testing even when new. The purpose of this study was to develop an inexpensive frame for damaged and poorly fitting masks using readily available materials and 3D printing. Results: An iterative design process yielded a mask frame consisting of two 3D printed side pieces, malleable wire links that users press against their face, and cut lengths of elastic material that go around the head to hold the frame and mask in place. Volunteers (n = 45; average BMI = 25.4), underwent qualitative fit testing with and without mask frames wearing one or more of four different brands of FFRs conforming to US N95 or Chinese KN95 standards. Masks passed qualitative fit testing in the absence of a frame at rates varying from 48 to 94 % (depending on mask model). For individuals who underwent testing using respirators with broken or defective straps, 80–100 % (average 85 %) passed fit testing with mask frames. Among individuals who failed fit testing with a KN95, ~ 50 % passed testing by using a frame. Conclusions: Our study suggests that mask frames can prolong the lifespan of N95 and KN95 masks by serving as a substitute for broken or defective bands without adversely affecting fit. Use of frames made it possible for ~ 73 % of the test population to achieve a good fit based on qualitative and quantitative testing criteria, approaching the 85–90 % success rate observed for intact N95 masks. Frames therefore represent a simple and inexpensive way of expanding access to PPE and extending their useful life. For clinicians and institutions interested in mask frames, designs and specifications are provided without restriction for use or modification. To ensure adequate performance in clinical settings, fit testing with user-specific masks and PanFab frames is required.


  • Open Access

    Medical student perceptions of assessment systems, subjectivity, and variability on introductory dermatology clerkships

    by Jaewon Yoon, Jordan T. Said, Leah L. Thompson, Gabriel E. Molina, Jeremy B. Richards, Steven T. Chen

    Elective introductory clerkships in dermatology serve a critical function in providing formative experiences to medical students interested in the field. Although dermatology clerkships play a pivotal role in students’ career choices and residency preparation, the assessment systems used to evaluate students on these clerkships are widely different and likely affect student experiences. This study aimed to explore the relationship between dermatology clerkship assessment systems and student experiences through interviews with students about their clerkship reflections and perceptions of assessment. The authors contacted clerkship directors via the Association of Professors of Dermatology mailing list and invited them to provide a description of the assessment system at their institution. The authors, via contacted clerkship directors, then invited students who had completed an introductory dermatology clerkship in between 2018 and 2019 to provide a description of the assessment system at their institution and to participate in a qualitative interview about their experiences with assessment systems. The authors then iteratively synthesized interview transcripts using phenomenological analysis, in which a templated approach was used to achieve comprehensive thematic categorization. Prior to clerkship onset, students expressed a limited understanding of their clinical role and the assessment system. During the clerkship, students endorsed variable expectations across preceptors, limited feedback experiences, and pressures to perform for evaluators. After their clerkship, students continued to perceive assessment systems as nontransparent, subjective, and preordained. Medical students perceived assessment systems on introductory dermatology clerkships to be unclear and arbitrary. Encouragingly, students also viewed these challenges in assessment as malleable, identifying several opportunities for educational reform in dermatology clerkships.


  • Effect of dermatological consultation on survival in patients with checkpoint inhibitor‐associated cutaneous toxicity

    by L.L. Thompson, E.B. Li, N.A. Krasnow, M.S. Chang, J.T. Said, G.E. Molina, N.J. Polyakov, J. Yoon, E.C. Dee, K. Huang, et al.

    Background Cutaneous immune‐related adverse events (cirAEs) are a common side effect of immune checkpoint inhibitors. However, prior work examining these toxicities in detail has considered only the fraction of events evaluated by dermatologists. Associations between dermatology referral, cirAE treatment, and survival outcomes remain underexplored across care settings. Objectives To comprehensively categorize cirAE patterns among all patients treated with immunotherapy at our institution, and to evaluate 1) the effect of dermatology referral on cirAE treatment, and 2) the impact of cirAE treatment on survival. Methods This was a retrospective cohort analysis of cancer patients who initiated ICI therapy between 1/1/16‐3/8/19 and developed one or more cirAE, as screened for using ICD‐10 codes and confirmed via manual chart review (n=358). All relevant information documented prior to 3/31/20 was included. Results CirAEs evaluated by dermatologists were significantly more likely to be treated than those not referred (OR=6.08, PP=0.001) and overall survival (HR=0.58, P=0.007) compared to those who did not. Conclusions CirAEs evaluated by dermatologists were significantly more likely to be treated than those that were not referred, and patients who received any treatment for cirAE had improved survival outcomes.


  • Open Access

    3D Printed frames to enable reuse and improve the fit of N95 and KN95 respirators

    by Malia McAvoy, Ai-Tram N. Bui, Christopher Hansen, Deborah Plana, Jordan T. Said, Zizi Yu, Helen Yang, Jacob Freake, Christopher Van, David Krikorian, et al.

    Background: In response to supply shortages during the COVID-19 pandemic, N95 filtering facepiece respirators (FFRs or “masks”), which are typically single-use devices in healthcare settings, are routinely being used for prolonged periods and in some cases decontaminated under “reuse” and “extended use” policies. However, the reusability of N95 masks is often limited by degradation or breakage of elastic head bands and issues with mask fit after repeated use. The purpose of this study was to develop a frame for N95 masks, using readily available materials and 3D printing, which could replace defective or broken bands and improve fit. Results: An iterative design process yielded a mask frame consisting of two 3D-printed side pieces, malleable wire links that users press against their face, and cut lengths of elastic material that go around the head to hold the frame and mask in place. Volunteers (n= 41; average BMI= 25.5), of whom 31 were women, underwent qualitative fit with and without mask frames and one or more of four different brands of FFRs conforming to US N95 or Chinese KN95 standards. Masks passed qualitative fit testing in the absence of a frame at rates varying from 48 – 92% (depending on mask model and tester). For individuals for whom a mask passed testing, 75-100% (average = 86%) also passed testing with a frame holding the mask in place. Among users for whom a mask failed in initial fit testing, 41% passed using a frame. Success varied with mask model and across individuals. Conclusions: The use of mask frames can prolong the lifespan of N95 and KN95 masks by serving as a substitute for broken or defective bands without adversely affecting fit. Frames also have the potential to improve fit for some individuals who cannot fit existing masks. Frames therefore represent a simple and inexpensive way of extending the life and utility of PPE in short supply. For clinicians and institutions interested in mask frames, designs and specifications are provided without restriction for use or modification. To ensure adequate performance in clinical settings, qualitative fit testing with user-specific masks and frames is required.